Navigation Links
Indivumed Study Provides Sound Scientific Basis for a Predictive,Drug Test- Platform

ver 6000 patient-cases, collected with a mean cold ischemia time of less than eight minutes, serves as a resource for Indivumed's cancer research in primary cells and biomarkers as well as for the use of pharmaceutical and biopharma partners.

CONTACT: Hartmut Juhl, M.D., Ph.D., CEO of Indivumed GmbH, T:+49-40-413383-10, F: +49-40-413383-14, E: ; or KevinSullivan, Director, Marketing and Sales of Indivumed, Inc., T:+1-301-588-4650, E: juhl@indivumed.com sullivan@indivumed.com

Web site: http://www.indivumed.com/

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea

Post Your Comments:
(Date:11/6/2009)...Newswire-FirstCall/ -- Recession in domestic and i...r Allied Healthcare Products in the first quarter ..., Sales declines pushed Allied into a loss for th... $745,000, or negative 9 cents per share, compared...0, or 3 cents per share. ,, Sales fell about 2...
(Date:11/6/2009)...Newswire/ -- Trius Therapeutics, Inc. announced to...Form S-1 with the U.S. Securities and Exchange Com...c offering of shares of its common stock. All shar...will be offered by the Company. ,, Credit Suiss...ing manager, Piper Jaffray & Co. is acting as ...
(Date:11/6/2009)...6 Repossessions and liquidations o...d quarter of 2009 declined as compared to similar ...ement,s NasTrac Quarterly Index (NQI). The figure...both repossessions and orderly liquidations, also ...ction and printing equipment, offering mixed news ...
Breaking Medicine Technology:Recession Continues to Depress Sales at Allied Healthcare Products 2Recession Continues to Depress Sales at Allied Healthcare Products 3Recession Continues to Depress Sales at Allied Healthcare Products 4Recession Continues to Depress Sales at Allied Healthcare Products 5Recession Continues to Depress Sales at Allied Healthcare Products 6NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 3NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 4Families Need to Know When Dementia Becomes Terminal 59478 1Families Need to Know When Dementia Becomes Terminal 59478 2Families Need to Know When Dementia Becomes Terminal 59478 3CDPHP Launches Individual Medicare Choices PPO Plan in the Capital Region 59475 1CDPHP Launches Individual Medicare Choices PPO Plan in the Capital Region 59475 2CDPHP Launches Individual Medicare Choices PPO Plan in the Capital Region 59475 3CDPHP Launches Individual Medicare Choices PPO Plan in the Capital Region 59475 4Fine Tuning Prosthetic Hands to Restore a Sense of Touch 59472 1Fine Tuning Prosthetic Hands to Restore a Sense of Touch 59472 2
...rstCall/ -- Avalon,Pharmaceuticals, Inc. , today a...Phase I clinical trial of AVN944 in hematologic,ma...ose of the U.S.,financial markets. The Company wil...0, 2007 at 8 a.m. Eastern Time. Interested,investo... public,can listen to the call over the Internet f...
... 2007 - Can-Fite,BioPharma (TASE:CFBI), a biotechn...e Exchange, proceeds with the development of its,t...ch is currently,in clinical trials and CF102, whic...will present at the EUALR annual congress of,rheum... effective,anti-inflammatory activity for CF502. T...
Other Medicine Technology:Avalon Updates the AVN944 Phase I Hematologic Malignancies Trial 2Avalon Updates the AVN944 Phase I Hematologic Malignancies Trial 3Can-Fite Proceeds with Development of Third Drug; Progress in,Development of CF502 Will Be Presented at the Annual European,Congress of Rheumatology 2
(Date:11/7/2009)...USTON, Nov. 7 Members o...duce an emergency resolution rescinding the AMA,s ...icians that they are responsible to their PATIENTS...kes, Director of Policy for the Association of Ame...ine, a coalition of other medical groups. ,, "...
(Date:11/7/2009)...Brown: "Faithful Catholics have a responsibility t...gotiate the status quo." ,, WASHINGTON, Nov. ...ue president Judie Brown released the following st...ll support Speaker Nancy Pelosi,s Affordable Healt...endment preserving the status quo for abortion is ...
(Date:11/7/2009)...SHINGTON, Nov. 7 Speake... availability this afternoon following a Democrati...Caucus Room. Below are the Speaker,s opening rema...it was a great occasion for us to receive the Pres...l be making history with our vote and making progr...
(Date:11/7/2009)...O, Nov. 7 The Public Relations Society of America...low on Diane Gage Lofgren, senior vice president o... Permanente, tonight at a ceremony at PRSA,s 2009 ... inducted into the PRSA College of Fellows is one ...id Michael Herman, APR, SAGE, Fellow PRSA, and 200...
(Date:11/7/2009)...ight back to stem a growing problem across the U.S... Nearly half of students at four-year colleges do ...inge drinking -- downing five or more alcoholic dr...tifying alcohol as a drug," said Jenny Hwang, asso...ing center at Stony Brook University on Long Islan...
Breaking Medicine News(10 mins):Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:Pelosi Remarks Following House Democrats' Meeting with President Obama 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 3Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 2Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 3
...chester Medical Center (URMC) announced today that... developer and philanthropist Richard T. Fields fo...largest private donation for a specific disease pr...cular dystrophy. , The new Fields Center for FSHD...
...he University of Michigan is the lead research ins...tium to study the health consequences on victims i...al Center for Disaster Mental Health Research, inc... is funded by the National Institutes of Health. ,...
...r blow to Trasylol, used to cut down on bleeding d...5 (HealthDay News) -- The U.S. Food and Drug Admin...ty of the clotting drug aprotinin (Trasylol), afte... the FDA in 1993, is typically used to limit blood...
...ME (BioMedical Enterprises, Inc.),today announced ... Medical,Director, was elected to BME,s Board of D...excelled in his leadership as,Medical Director of ...e to the BOD over this year has demonstrated,his i...
...venue, Net Income and EPS; Revenue, Net...., Oct. 25 MICROS Systems, Inc.,(Nasdaq: MCRS ),...hospitality and retail industries, today announced...rease of $42.8 million, or 24.6%, over the sam...
...s to switch the wrigglers, orientation , THURSDAY,...hard-wired into the brains of small worms called n...ed some of the creatures to make them attracted to...y are about worms and how attraction behaviors are...
Other Medicine News:Health News:New center to lead international muscular dystrophy research effort 2Health News:New center to lead international muscular dystrophy research effort 3Health News:New center to lead international muscular dystrophy research effort 4Health News:U-M to lead disaster aftermath research center 2Health News:FDA to Review Clotting Drug After Trial Suggests Death Risk 2Health News:FDA to Review Clotting Drug After Trial Suggests Death Risk 3Health News:FDA to Review Clotting Drug After Trial Suggests Death Risk 4Health News:MICROS Reports Fiscal 2008 First Quarter Results 2Health News:MICROS Reports Fiscal 2008 First Quarter Results 3Health News:MICROS Reports Fiscal 2008 First Quarter Results 4Health News:MICROS Reports Fiscal 2008 First Quarter Results 5Health News:MICROS Reports Fiscal 2008 First Quarter Results 6Health News:MICROS Reports Fiscal 2008 First Quarter Results 7Health News:Worm Study Points to Sexuality's Origins 2
Ezy Wrap® Economy Knee Immobilizer
QualCraft™ Knee w/MultiLock Polyamide Hinge
...tic benefits of controlled compression to minimize...ain. The cuff is anatomically designed to complete... Knee Cryo/Cuff is available in three sizes for ad...signed for children 1 - 7 years of age. A sterile ...
DuraSoft Shoulder Wrap and Back Wrap
Medicine Products: